You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Newly Diagnosed Standard Risk Multiple Myeloma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Newly Diagnosed Multiple Myeloma Trial (Daratumumab)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • (no location specified)
Oct 10, 2021

Multiple Myeloma Trial in Tampa (Lenalidomide, Prednisone, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Oct 8, 2021

High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • High-Risk de Novo Multiple Myeloma
  • Badalona, Spain
  • +9 more
Apr 27, 2023

Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Wuhan, Hubei, China
    Institute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023

Multiple Myeloma Trial in France (Ixazomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Bordeaux, France
  • +11 more
Jul 29, 2020

Clinical Pathways for Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Multiple Myeloma Without Mention of Remission
  • Multiple Myeloma Pathway
  • +2 more
  • (no location specified)
Nov 27, 2023

Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Guangzhou, Guangdong, China
  • +3 more
Aug 16, 2022

Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Hamburg, Germany
  • +3 more
Dec 16, 2022

Stem Cells Mobilization, colLection and Engraftment in Newly

Recruiting
  • Multiple Myeloma
  • +3 more
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Frailty
    • (no location specified)
    Oct 30, 2023

    Multiple Myeloma Prognostic Indices

    Recruiting
    • Multiple Myeloma
    • Hematologic Diseases
    • blood viscosity , albumin / fibrinogen ratio and red cell distribution
    • Assiut, Egypt
      Assiut University hospital
    Oct 17, 2023

    Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

    Recruiting
    • Multiple Myeloma
    • New Diagnosis Tumor
    • BCMA CAR-T cells
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Jan 31, 2023

    Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

    Not yet recruiting
    • Multiple Myeloma
    • Renal Failure
    • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
    • Augusta, Georgia
      Georgia Cancer Center-Augusta University
    Nov 16, 2023

    Multiple Myeloma, Cancer Trial in Chapel Hill, Durham, Columbus (Isatuximab, Lenalidomide, Dexamethasone)

    Recruiting
    • Multiple Myeloma
    • Cancer
    • Chapel Hill, North Carolina
    • +2 more
    Jun 30, 2022

    Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Drug and medical device
    • Poitiers, France
      CHU Poitiers
    Jun 1, 2023

    Multiple Myeloma Trial in Cleveland (Palliative Care, FACT-MM questionnaire, HADS questionnaire)

    Recruiting
    • Multiple Myeloma
    • Palliative Care
    • +2 more
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    Jan 17, 2023

    MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With

    Not yet recruiting
    • Multiple Myeloma
    • Minimal Residual Disease
      • (no location specified)
      Nov 1, 2023

      Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the

      Not yet recruiting
      • Multiple Myeloma
      • +2 more
      • 18F-fluciclovine injection
      • 18F-FDG PET/CT
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Oct 31, 2023

      Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

      Recruiting
      • Newly Diagnosed Multiple Myeloma
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Dec 29, 2022

      Multiple Myeloma Trial (Teclistamab, Daratumumab, Lenalidomide)

      Not yet recruiting
      • Multiple Myeloma
      • (no location specified)
      Oct 6, 2022

      Multiple Myeloma Trial in Torino (Lenalidomide, Dexamethasone)

      Active, not recruiting
      • Multiple Myeloma
      • Torino, Italy
        FO.NE.SA.Onlus
      Mar 24, 2022

      Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)

      Recruiting
      • Multiple Myeloma
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital Chinese Acad
      May 12, 2023

      Daratumumab in Combination With Bortezomib, Thalidomide, and

      Not yet recruiting
      • Newly Diagnosed Multiple Myeloma
      • Daratumumab in Combination with Bortezomib, Thalidomide, and Dexamethasone Regimens
      • (no location specified)
      Sep 27, 2022

      Multiple Myeloma Trial in China (Selinexor, Bortezomib, Lenalidomide)

      Recruiting
      • Multiple Myeloma
      • Changzhou, Jiangsu, China
      • +5 more
      Jun 11, 2023

      Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

      Active, not recruiting
      • Plasma Cell Myeloma
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Jan 10, 2023